ga

Skip to content

My Files [0]

These are the files you have added to your collection.

  • You don't have any documents yet, feel free to browse the website and add documents.
Top

Health Technology Assessment

Subscribe (RSS)

Results 1 - 20 of 186

  1. Technology Reports

  2. Technology Reports

    Robot-assisted Surgery versus Open Surgery and Laparoscopic Surgery: Clinical Effectiveness and Economic Analyses

    September 21, 2011

    Report Summary A few Canadian hospitals have developed surgical robotics programs using technology such as the Da Vinci® Surgical System, to help surgeons perform surgery. This technology is however associated with significant capital and operating costs. Given the relatively recent introduction...

  3. Technology Reports

    Vancomycin or Metronidazole for Treatment of Clostridium difficile Infection: Clinical and Economic Analyses

    January 26, 2011

    This report focuses on first-line treatment using vancomycin or metronidazole for initial or recurrent moderate to severe Clostridium difficile infection.  Clinical, economic, and health services impact considerations are evaluated. Report This report has been extensively peer-reviewed by exter...

  4. Technology Reports

    Clopidogrel versus Other Antiplatelet Agents: A CADTH Technology Assessment Report Series

    November 26, 2010

    This series of three health technology assessments examines the clinical and cost-effectiveness of Clopidogrel (alone or in combination with acetylsalicylic acid i.e., ASA) versus other antiplatelet agents (ASA, ticlopidine, dipyridamole, extended-release dipyridamole 200 mg/ASA 25 mg combination) f...

  5. Technology Reports

  6. Technology Reports

  7. Technology Reports

    Pharmacologic-based Strategies for Smoking Cessation

    September 21, 2010

    Smoking is one of the major risk factors for cancer, respiratory disease, and cardiovascular disease. Smoking tobacco is a risk factor that can be changed — by quitting permanently. Unfortunately, quitting smoking is much easier said than done. So how can we best help smokers to quit? Which of...

  8. Technology Reports

    Bariatric Surgery for Severe Obesity: Systematic Review and Economic Evaluation

    September 20, 2010

    The Canadian Agency for Drugs and Technologies in Health (CADTH) conducted a systematic review and primary economic evaluation to assess the clinical effectiveness, cost-effectiveness, and health services impact of bariatric surgery procedures for the management of severe obesity. Report This report...

  9. Technology Reports

    Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses

    September 17, 2010

    Atrial fibrillation (AF) is a type of heart rhythm disturbance or arrhythmia that affects over 200,000 Canadians, including more than 5% of the population over the age of 65. The most common type of arrhythmia, AF is associated with a high degree of morbidity and mortality, including an increased ri...

  10. Technology Reports

  11. Technology Reports

    Triple Therapy for Moderate-to-Severe Chronic Obstructive Pulmonary Disease

    May 5, 2010

    The Canadian Agency for Drugs and Technologies in Health (CADTH) conducted a systematic review and primary economic evaluation to evaluate the clinical effectiveness, cost-effectiveness, and health services impact of triple therapy in the treatment of moderate-to-severe chronic obstructive pulmonar...

  12. Technology Reports

    Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

    March 29, 2010

    The Canadian Agency for Drugs and Technologies in Health (CADTH) conducted a systematic review to evaluate the clinical, economic and budgetary implications of pulmonary rehabilitation (PR) programs to assist policy-makers and health care providers with future decisions in the establishment and util...

  13. Technology Reports

  14. Technology Reports

    Recombinant Activated Factor VII for Prevention of Bleeding Unrelated to Hemophilia: Clinical and Economic Systematic Review

    February 4, 2010

    CADTH’s health technology assessment report examines the clinical efficacy and cost-effectiveness of off-label use of recombinant activated factor VII (rFVIIa), an agent currently approved to control bleeding in patients with either hemophilia A or B and clotting factor inhibitors.  ...

  15. Technology Reports

    Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease: Clinical and Cost-Effectiveness Analyses

    December 22, 2009

    CADTH’s health technology assessment report on clopidogrel versus other antiplatelet agents examines the clinical efficacy and cost-effectiveness of this treatment strategy for secondary prevention of vascular events in adults with cerebrovascular disease. The report also assesses current...

  16. Technology Reports

    Addendum to the Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products

    December 22, 2009

    This addendum to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition) is intended to provide specific guidance on the methods used to conduct high-quality economic evaluations of oncology products. The oncology-specific guidelines should be considered a companion...

  17. Technology Reports

    Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada

    December 9, 2009

    An amendment to this report to reflect the inclusion of additional portable monitoring devices that are licensed in Canada has been made. The revised report is now available. View Report (38 pages) View Executive Summary (3 pages) Context and Policy Issues Obstructive sleep apnea (OSA) is a synd...

  18. Technology Reports

    Reassessment of Health Technologies: Obsolescence and Waste

    December 4, 2009

    CADTH’s report on the reassessment of health technologies is intended to inform and encourage further discussion about the appropriate use of existing health technologies. This report considers practical and policy issues related to health technology obsolescence and proposes a framework for t...

  19. Technology Reports

    Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation

    November 13, 2009

    CADTH’s health technology assessment report on long-acting beta2-agonist (LABA) and inhaled corticosteroid (ICS) combination therapy examines the clinical efficacy, safety, and cost-effectiveness of this treatment strategy for adult persistent asthma. This assessment focuses on LABA-ICS c...

  20. Technology Reports